Xiao Yun-Bei, Xie Jing, Zhang Gou-Xi, Li Jing, Hao Yi-Chang, Zhang Xiao-Wei, Liu Zhen-Hua, Xu Tao, Wang Xiao-Feng
Department of Urology, People's Hospital of Peking University, Beijing 100044, China.
Zhonghua Nan Ke Xue. 2012 Mar;18(3):195-9.
To investigate the inhibitory effect of CKLF-like MARVEL transmembrane domain containing 5 (CMTM5) on xenografted human prostatic cancer in nude mice and its action mechanism.
We established a model of xenografted prostatic cancer by inoculating PC-3 cells subcutaneously into nude mice, and 3 weeks later injected CMTM5 adenovirus locally into the tumor followed by daily observation of the tumor volume and body weight of the experimental animals. All the rats were killed 2 weeks after CMTM5 injection and the tumor tissue harvested for detection of the inhibitory effect of CMTM5 on the expressions of VEGF and NF-kappaB proteins by immunohistochemistry.
The tumor volume was significantly smaller and body weight of the CMTM5-treated mice were (573.39 +/- 175.24) mm3 and (0.55 +/- 0.11) g, respectively, significantly decreased as compared with those of the controls ([1482.50 +/- 327.86] mm3 and [1.31 +/- 0.29] g) (P = 0.03 and P = 0.027). Immunohistochemistry showed that the expressions of VEGF and NF-kappaB were obviously down-regulated in the CMTM5 group in comparison with the control group.
CMTM5 suppresses the growth of prostate cancer by down-regulating the expressions of VEGF and NF-kappaB.
探讨含CKLF样MARVEL跨膜结构域5(CMTM5)对裸鼠人前列腺癌移植瘤的抑制作用及其作用机制。
将PC-3细胞皮下接种于裸鼠建立前列腺癌移植瘤模型,3周后将CMTM5腺病毒局部注射到肿瘤内,随后每天观察实验动物的肿瘤体积和体重。注射CMTM5后2周处死所有大鼠,取肿瘤组织,通过免疫组化检测CMTM5对VEGF和NF-κB蛋白表达的抑制作用。
CMTM5处理组小鼠的肿瘤体积明显较小,体重分别为(573.39±175.24)mm³和(0.55±0.11)g,与对照组([1482.50±327.86]mm³和[1.31±0.29]g)相比显著降低(P = 0.03和P = 0.027)。免疫组化显示,与对照组相比,CMTM5组VEGF和NF-κB的表达明显下调。
CMTM5通过下调VEGF和NF-κB的表达抑制前列腺癌的生长。